Abbott Laboratories “purposely marketed” toddler milks to portray them as the next recommended step in a child’s diet – but ...

Formulas marketed for toddlers are a burgeoning business, but pediatricians have long recommended against their use.

Abbott Laboratories engages in the discovery ... Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Abbott Laboratories’ ABT growth in the ... expanding on strong global demand for the company’s adult nutrition products. In the third quarter of 2024, the company reported 3.4% organic growth ...

In our view, the biggest risks Abbott faces include ongoing difficulties with its left ventricular assist devices, and the potential commercial success of its Libre franchise, which includes planned ...

The Public Health Advocacy Institute (PHAI) today announced that it has filed a class action lawsuit in the United States ...